UBS AM’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,029
| Closed | -$50.9K | – | 2611 |
|
|
2023
Q3 | $50.9K | Hold |
1,029
| – | – | ﹤0.01% | 2578 |
|
|
2023
Q2 | $93.2K | Hold |
1,029
| – | – | ﹤0.01% | 2646 |
|
|
2023
Q1 | $93.2K | Buy |
+1,029
| New | +$93.2K | ﹤0.01% | 2646 |
|
|
2022
Q4 | – | Sell |
-628
| Closed | -$114K | – | 2754 |
|
|
2022
Q3 | $114K | Sell |
628
-693
| -52% | -$126K | ﹤0.01% | 2673 |
|
|
2022
Q2 | $118K | Hold |
1,321
| – | – | ﹤0.01% | 2631 |
|
|
2022
Q1 | $205K | Hold |
1,321
| – | – | ﹤0.01% | 2673 |
|
|
2021
Q4 | $393K | Buy |
1,321
+142
| +12% | +$42.3K | ﹤0.01% | 2621 |
|
|
2021
Q3 | $680K | Buy |
1,179
+598
| +103% | +$345K | ﹤0.01% | 2349 |
|
|
2021
Q2 | $264K | Buy |
+581
| New | +$264K | ﹤0.01% | 2668 |
|